Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Albireo Sets Sights On Rare Disease Model
First Indication Under Review, With Plans For Two More
Feb 19 2021
•
By
Joseph Haas
Albireo looked at the successes of other rare disease firms as it moves toward its first approval
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Rare Diseases
More from Scrip